Skip to main content


Decorative image
Observing World Asthma Month Every Day in May There are many organizations providing opportunities for the May 2, 2023 observance of World Asthma Day and World Asthma Month, which is in May each year.
Decorative image
Severe Asthma Clinical Practice Course at ATS 2023 What are the latest recommendations for the management of severe asthma? See details about a post-graduate course being offered at ATS 2023.
Decorative image
Moderate to Severe Asthma: A Podcast Series

A limited podcast series is now available that takes a deep dive into the diagnosis, treatment, and ongoing care of patients with moderate to severe asthma. Produced by Medscape, the “InDiscussion: Moderate to Severe Asthma” podcast series is an in-depth interview style-look at the field of asthma.

Decorative image
Severe Asthma The PrecISE Clinical Trial, Time Commitment, New Type of Asthma Study, Compensation, Enroll.
Decorative image
Publications Update - The Study's Design Latest publications - see the list here.
Portrait of Dr. Loren Denlinger
American Thoracic Society and PrecISE Present Webinar on Severe Asthma for World Asthma Day The webinar will be held on May 5 from 12-1pm EDT and coincides with this year’s annual observance of World Asthma Day. Register to attend.
Screencapture of a video frame, with text transcribed that says "severe asthma patients."
Why PrecISE - Better ways to treat severe asthma - Watch the video PrecISE is a network looking for better ways to treat teens and adults with severe asthma - learn more in this video.
Decorative image - hospital Emergency Room sign in red letters
PrecISE Co-Investigator Honored as “Hero Doc” by New York Post

Dr. Michael Peters is a west-coast based physician and researcher at the University of California – San Francisco (UCSF). He sees asthma patients there at the Severe Asthma Clinic and is an attending at the UCSF Critical Care Unit.

A native of New York, Dr. Peters’ thoughts turned to home as the medical response to the coronavirus intensified in New York.

Study logo, says PrecISE Precision Interventions for Severe Asthma, in blue and green with decorative icon of a set of lungs
COVID-19 Response and the PrecISE Research Study Safety is our number one priority, for patients, their families, and our team members who work on all aspects of PrecISE.
An employee at the University of Pittsburgh shows how a clinical measurement device is used.
Recruitment and Screening for PrecISE Clinical Study Opens The PrecISE novel clinical trial, which applies precision medicine to severe asthma treatment, reached a major milestone with the opening of recruitment and screening at two study site locations.
twitter link